A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
Clinical trial NCT06497452 · UNKNOWN
Trial details
- NCT number
- NCT06497452
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.